Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
04:01pm, Wednesday, 07'th Jan 2026
THOUSAND OAKS, Calif., Jan. 7, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2026 J.P.
Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs
01:45pm, Wednesday, 07'th Jan 2026
On Tuesday, Amgen Inc. (NASDAQ: AMGN) acquired Dark Blue Therapeutics, a discovery and development biotech company focused on precision oncology medicines.
Amgen Buys Dark Blue Therapeutics to Strengthen Oncology Pipeline
09:35am, Wednesday, 07'th Jan 2026
AMGN's $840M buyout of Dark Blue Therapeutics adds a preclinical AML degrader, bolstering its oncology pipeline.
CX Institutional Increases Stake in Amgen Inc. $AMGN
05:55am, Wednesday, 07'th Jan 2026
CX Institutional increased its stake in Amgen Inc. (NASDAQ: AMGN) by 9.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission
Cerity Partners LLC Sells 6,837 Shares of Amgen Inc. $AMGN
05:04am, Wednesday, 07'th Jan 2026
Cerity Partners LLC reduced its stake in Amgen Inc. (NASDAQ: AMGN) by 1.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The
Amgen Agrees to Buy Dark Blue Therapeutics in Up to $840 Million Deal
12:07pm, Tuesday, 06'th Jan 2026
Amgen (AMGN) has agreed to acquire UK-based cancer drug developer Dark Blue Therapeutics in a deal valued at up to $840 million, as the company looks to reinfor
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Tuesday, 06'th Jan 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
09:00am, Tuesday, 06'th Jan 2026
Acquisition Adds Differentiated Investigational Molecule Designed to Treat Acute Myeloid Leukemia THOUSAND OAKS, Calif., Jan. 6, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced its acquisiti
Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors
07:00pm, Monday, 05'th Jan 2026
In the closing of the recent trading day, Amgen (AMGN) stood at $320.71, denoting a -2.12% move from the preceding trading day.
Railway Pension Investments Ltd Has $27.18 Million Position in Amgen Inc. $AMGN
07:18am, Monday, 05'th Jan 2026
Railway Pension Investments Ltd raised its stake in Amgen Inc. (NASDAQ: AMGN) by 9.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC
Davis Capital Management Makes New Investment in Amgen Inc. $AMGN
04:20am, Sunday, 04'th Jan 2026
Davis Capital Management bought a new stake in shares of Amgen Inc. (NASDAQ: AMGN) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The f
Dogs Of The Dow: 10 High-Yield Stocks With Dividends Up To 6.8% - Including Several Warren Buffett Favorites
05:06pm, Friday, 02'nd Jan 2026
The 10 highest paying dividend stocks in the Dow Jones Industrial Average offer yields from 2.5% to 6.8%. A look at the Dogs of the Dow.
Amgen Inc. $AMGN Shares Purchased by Econ Financial Services Corp
04:52am, Friday, 02'nd Jan 2026
Econ Financial Services Corp increased its position in shares of Amgen Inc. (NASDAQ: AMGN) by 63.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commi
Braun Stacey Associates Inc. Has $1.27 Million Stock Holdings in Amgen Inc. $AMGN
03:36am, Friday, 02'nd Jan 2026
Braun Stacey Associates Inc. reduced its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 88.6% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The in
These three ‘Dogs of the Dow' stocks are must-own for 2026
12:12pm, Wednesday, 31'st Dec 2025
The “Dogs of the Dow” strategy has staged a comeback, and Kevin Simpson of Capital Wealth Planning believes 2026 could be another strong year. After a 17% gain in 2025, beating the broader Dow's p
